Logo for Achieve Life Sciences Inc

Achieve Life Sciences Investor Relations Material

Latest events

Logo for Achieve Life Sciences Inc

Q3 2024

Achieve Life Sciences
Logo for Achieve Life Sciences

Q3 2024

7 Nov, 2024
Logo for Achieve Life Sciences

Q2 2024

13 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Achieve Life Sciences Inc

Access all reports
Achieve Life Sciences, Inc. is a biopharmaceutical company focused on the development and commercialization of therapies to aid in smoking cessation. The company’s lead product candidate is based on cytisinicline, a plant-based alkaloid that is being developed to help people quit smoking by reducing nicotine cravings and withdrawal symptoms. Achieve Life Sciences is engaged in clinical trials to advance its therapeutic offerings aimed at addressing nicotine addiction. The company is headquartered in Seattle, United States, and its shares are listed on the NASDAQ.